[Federal Register Volume 86, Number 23 (Friday, February 5, 2021)]
[Notices]
[Page 8381]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2021-02454]


-----------------------------------------------------------------------

DEPARTMENT OF JUSTICE

Drug Enforcement Administration

[Docket No. DEA-771]


Bulk Manufacturer of Controlled Substances Application: Noramco, 
Inc.

AGENCY: Drug Enforcement Administration, Justice.

ACTION: Notice of application.

-----------------------------------------------------------------------

SUMMARY: Noramco Inc has applied to be registered as a bulk 
manufacturer of basic class(es) of controlled substance(s). Refer to 
Supplemental Information listed below for further drug information.

DATES: Registered bulk manufacturers of the affected basic class(es), 
and applicants therefore, may file written comments on or objections to 
the issuance of the proposed registration on or before April 6, 2021. 
Such persons may also file a written request for a hearing on the 
application on or before April 6, 2021.

ADDRESSES: Written comments should be sent to: Drug Enforcement 
Administration, Attention: DEA Federal Register Representative/DPW, 
8701 Morrissette Drive, Springfield, Virginia 22152.

SUPPLEMENTARY INFORMATION: In accordance with 21 CFR 1301.33(a), this 
is notice that on November 3, 2020, Noramco Inc, 1550 Olympic Drive, 
Athens Georgia 30601, applied to be registered as an bulk manufacturer 
of the following basic class(es) of controlled substance(s):

------------------------------------------------------------------------
                                           Drug
          Controlled substance             code          Schedule
------------------------------------------------------------------------
Gamma Hydroxybutyric Acid...............    2010  I
Marihuana Extract.......................    7350  I
Marihuana...............................    7360  I
Tetrahydrocannabinols...................    7370  I
Codeine-N-oxide.........................    9053  I
Dihydromorphine.........................    9145  I
Hydromorphinol..........................    9301  I
Nabilone................................    7379  II
Codeine.................................    9050  II
Dihydrocodeine..........................    9120  II
Oxycodone...............................    9143  II
Hydromorphone...........................    9150  II
Hydrocodone.............................    9193  II
Levorphanol.............................    9220  II
Morphine................................    9300  II
------------------------------------------------------------------------

    The company plans to manufacture bulk active pharmaceutical 
ingredients (API) and reference standards for distribution to their 
customers.
    In reference to drug codes 7350 (Marihuana Extract), 7360 
(Marihuana), and 7370 (Tetrahydrocannabinols), the company plans to 
bulk manufacture these drugs as synthetics. No other activities for 
these drugs are authorized for this registration.

William T. McDermott,
Assistant Administrator.
[FR Doc. 2021-02454 Filed 2-4-21; 8:45 am]
BILLING CODE P